<unk>  (OHPA), sold under the brand name Prodox, is an orally active progestin related to<unk>  caproate (OHPC) which has been used in clinical and veterinary medicine. It has reportedly also been used in birth control pills. OHPA is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone. OHPA was discovered in 1953 and was introduced for medical use in 1956.
Hydroxyprogesterone acetate
Medroxyprogesterone acetate
Retroprogesterone
Desoxymethyltestosterone
Gestodene
Lipoidal estradiol
Vinyltestosterone
Hydroxyprogesterone caproate